Safe Harbor Clinical Research is a clinical research site located in East Providence, Rhode Island, United States 02914.
Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Safe Harbor Clinical Research has participated in 18 clinical trials.
Therapeutic areas: Diabetes Mellitus, Type 2, Type 2 Diabetes Mellitus, Lung Cancer (Diagnosis).
Sponsors: AstraZeneca, Exact Sciences Corporation, Oxford Immunotec.
Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Safe Harbor Clinical Research has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Safe Harbor Clinical Research has 18 clinical trials on record. Their work covers Diabetes Mellitus, Type 2, Type 2 Diabetes Mellitus, Lung Cancer (Diagnosis).
Safe Harbor Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.